SavedAdd your journal

Journals / MN Kardiyoloji / 2003 / Cilt: 10 - Sayı: 1

Occurence of a long QT and torsades de pointes with the concomitant use of amiodarone, vancomycin, meropenem and lansoprazol: A case report

Amiodaron, vankomisin, meropenem ve lansoprazolun beraber kullanımı sırasında ortaya çıkan uzun QT ve torsades de pointes: Olgu sunumu

Deniz KAYA
ALPER CANBAY
Telat KELEŞ
Candan AVAN
Sinan AYDOĞDU
Erdem DİKER
Pages
41–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herewith, we briefly discussed drug induced TdP's.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Torsades de pointes is a specific type of polimorphic tachycardia, associated with prolonged QT interval.
📊
Key Findings & Data:Drugs that prolong QT interval is one of the important cause of torsades de pointes.
💡
Conclusion & Impact:Herewith, we briefly discussed drug induced TdP's.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Amiodaron · Vankomisin · Omeprazol

Abstract

Torsades de pointes is a specific type of polimorphic tachycardia, associated with prolonged QT interval. Drugs that prolong QT interval is one of the important cause of torsades de pointes. We report a case with long QT and TdP concomitant use of amiodarone, antibiotics and proton pump inhibitors. Herewith, we briefly discussed drug induced TdP's.

Özet

Torsades de pointes, QT intervalinin uzaması ile birlikte olan spesifik bir polimorfik takikardidir. QT intervalini uzatan ilaçlar torsades de pointesin en önemli nedenlerinden biridir.Burada, amiodaron ve beraberinde antibiotik ile proton pompa inhibitörlerinin kullanıldığı bir olguda ortaya çıkan uzun QT ve TdP olgusu bildirilmiştir. Olgu nedeniyle ilaç etkisi ile oluşan TdP' ler tartışılmıştır.

🔖

Cite This Article

KAYA, D., CANBAY, A., KELEŞ, T., AVAN, C., AYDOĞDU, S., DİKER, E. (2003). Occurence of a long QT and torsades de pointes with the concomitant use of amiodarone, vancomycin, meropenem and lansoprazol: A case report. MN Kardiyoloji, Cilt: 10 - Sayı: 1, 41–44. https://ajindex.com/articles/297666

References (14)

  1. Pasmann R, Kadish A. Polymorphic ventricular tachycardia, Dng QT syndrome and torsades de pointes. Medical Clinics of Jorth America 2001; 85:321-41. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine: 2001:721-34.
  2. Dorsey TS, Biblo LA. Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline. Am J Emerg Med 2000; 18:227-9.
  3. Tholakanahalli VN, Potti A, Hanley JF, et al. Fluconazole induced torsade de pointes. Ann Pharmacother 2001; 35:432-4.
  4. Abernethy DR, Barbey JT, Franc C, et al. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation. Clin Pharmacol Ther 2001; 39:96-103. Dessertenne F. Ventricular tachycardia with two variable opposing foci. Arch Mai Coeur Vaiss 1966; 59:263-72.
  5. Khan Al, Win MT, Bali A, et al. Torsade de pointes: A case with multiple variables. Am J Emerg Med 1999; 17:80-5.
  6. Grimm W, Steder U, Menz V, et al. Effect of amiodarone on QT dispersion in the 12-lead electrocardiogram and its signifi cance for subsequent arrhymic events. Clin Cardiol 1997; 20:107-10.
  7. Jackman W, Friday K, Anderson J, et al. The long QT syndromes: A critical review, new clinical observations and unifying hypothesis. Prog Cardivasc Dis 1988; 31:115-72.
  8. Skanes AC, Morton BC, Green MS, et al. Torsade de pointes with amiodarone in a patient with previous torsade during beta receptor blockade. Can J Cardiol 1997; 13:383-6. Grossman MA. Cardiac arrhythmias in acute central nervous system disease. Arch intern Med 1976; 136:203-7.
  9. Ludomirsky A, Klien HO, Sarelli P, et al. Q-T prolngation and polymorphous ventricular arrhythmias associated with organop- hosphate insecticide poisoning. Am J Cardiol 1982; 49:1654-8.
  10. Loeb HS, Stang JM, Gunnar RM, et al. Paroxysmal ventricular fibrillation in two patients with hypomagnesemia: Treatment by transvenous pacing. Circulation 1968; 37:210-5.
  11. Singh BN, Gaarder TD, Kanegae T, et al. Liquid protein diets and torsade de pointes. JAMA 1978; 240:115-9.
  12. Tchou P, Atassi K, Jazayeri M, et al. Etiology of polimorphic VT in the absence of a prolonged QT. J Am Coll Cardiol 1989; 13:21A. Kay G, Plumb V, Arciniegas J, et al. Torsades de pointes: The long -short initiating sequence and other clinical features. J Am Coll Cardiol 1983; 2:806-17.
  13. Keren A, Tzivoni D, Gavish D, et al. Etiology.warning signs and therapy of torsade de pointes. Circulation 1981; 64:1167-74.
  14. Roden D, Woosely R, Primm R. Incidence and clnical features of qui